Related Experiment Videos
International comparisons of pharmaceutical prices: what do we know, and what does it mean?
Journal of Health Economics
|August 18, 2000
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Comparing SSRI treatment costs for depression using retrospective claims data: the role of nonrandom selection and skewed data.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2006
Healthcare expenditure in patients treated with venlafaxine or selective serotonin reuptake inhibitors for depression and anxiety.
International journal of clinical practice·2002
The U.S. pharmaceutical industry: why major growth in times of cost containment?
Health affairs (Project Hope)·2001
Health care use and at-work productivity among employees with mental disorders.
Health affairs (Project Hope)·2000
Lost human capital from early-onset chronic depression.
The American journal of psychiatry·2000
Labor unions and deaths of despair: Evidence from right-to-work laws.
Journal of health economics·2026
Contagion, migration, and misallocation in a pandemic.
Journal of health economics·2026
Hospital Billing Regulations and Financial Well-being: Evidence from California's Fair Pricing Law.
Journal of health economics·2026
Consolidation of Local Health Authorities and mortality in the Italian NHS.
Journal of health economics·2026
The effect of health insurance expansion on price and demand for medications among the uninsured.
Journal of health economics·2026
Mirogabalin, C12H19NO2, and mirogabalin besylate, C12H20NO2+·C6H5O3S.
Acta crystallographica. Section C, Structural chemistry·2026
What is in the bottle? An analysis of the ingredients in menopause supplements.
Climacteric : the journal of the International Menopause Society·2026
Non-Prescribed Gabapentinoid Use: Demographic and Behavioural Risk Profiles in a Large International Sample.
Drug and alcohol review·2026
Effects of intestinal permeation enhancers on solubilization and epithelial transport of the proteolysis targeting chimera (PROTAC) ARV-471 in rats.
Journal of controlled release : official journal of the Controlled Release Society·2026
Special Populations in Pivotal Clinical Trials: Eligibility and Supporting Evidence for Exclusion in EMA-Authorised Medicines.
Clinical pharmacology and therapeutics·2026